Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma.
about
Modulation of Chemokine Responses: Synergy and CooperativityBeyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphomaChemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking.Pathway analysis of primary central nervous system lymphoma.Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals.Biology and treatment of primary central nervous system lymphoma.Treatment options for central nervous system lymphomas in immunocompetent patients.Regulated Production of CXCL13 within the Central Nervous System.Progress in central nervous system lymphomas.Insights into the biology of primary central nervous system lymphomaThe future of primary intraocular lymphoma (retinal lymphoma).Lymphoid chemokines in the CNS.Constitutive non-canonical NFkappaB signaling in pancreatic cancer cellsSelective central nervous system tropism of primary central nervous system lymphoma.Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma.A role for CXCL13 (BCA-1) in pregnancy and intra-amniotic infection/inflammation.Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma.Murine model of primary intraocular lymphoma.Dysregulated Epstein-Barr virus infection in the multiple sclerosis brainCXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.Targeting CXCL13 During NeuroinflammationExpression and regulation of activated leukocyte cell adhesion molecule in human retinal vascular endothelial cells.CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphomaSerum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma riskChemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of miceNew approaches in primary central nervous system lymphoma.How I treat CNS lymphomas.Pathophysiology of retinal lymphoma.Diagnosis and management of primary intraocular lymphoma: an updateInterleukin-1β pre-treated bone marrow stromal cells alleviate neuropathic pain through CCL7-mediated inhibition of microglial activation in the spinal cord.Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target.The challenge of the microenvironment in B-cell lymphomas.Circulating biomarkers of CNS tumors: an update.How we diagnose and treat vitreoretinal lymphoma.The Challenge of Primary Central Nervous System Lymphoma.
P2860
Q26744643-A4DEDCA5-E979-481B-8255-10676B7F8E43Q27013785-87BED0F4-3CA5-4850-AA7A-03E65A17BCDDQ27693462-582F71EE-57F7-4DEC-8EEC-17B17A3D8F02Q30481424-37550C56-AF6B-40F4-B526-B3440EE3528EQ33261904-1E03E28E-3D90-460A-ABEF-7EAE167ED43EQ33450339-AD3DC5E7-9DDE-44C1-BAC4-3733389DEBE1Q33475480-40CF31E5-98C0-4080-80B4-C4270E0E42D6Q33510785-D859311A-C332-4E8E-BCD2-358C33E729E7Q33772300-B206962A-8C22-409C-9405-B1AB52AE4F62Q33934406-7A6ED082-BB82-4842-9AD4-C3FB852DB0A1Q33946618-40A20565-9D16-4AE5-9844-C4F7897DC3AEQ33950795-0F122B46-7DC7-40DA-90DE-955472EDBD43Q34020894-A5686F03-2A14-479A-B83E-B798E37058B2Q34021737-0E9194BE-D0B2-46D9-9676-72A8E11CC750Q34357903-F3F308C2-4C6B-4476-BF4D-CC1A04011CDAQ34373668-2F7C28BF-F83F-4FD9-905F-B4775AE1B333Q34504952-EF65328C-6EE9-4D4D-BF3A-125F87396066Q34730335-1ACAD018-9ED2-4ED5-9AD9-296F068A59B8Q35205183-B6F0E127-C20F-4B26-810C-18C1B1AD6C93Q35599811-F8A8CF34-133A-4674-80A4-B66D2399FD67Q35910879-D9F1B632-E143-4ECB-9ADA-9AC142FE8AF6Q35944983-4BE59A00-6812-4A86-91D3-56102F3F01F0Q36229219-6D0E75AD-ED94-48AB-B069-9A2BC1CEE059Q36515088-74CA86A8-6CCC-44EE-AD4C-4F526A9A73A6Q36551188-84360025-B5E9-49CE-BDE6-75DCD112EA22Q36566608-E608C163-8BE7-4188-B2B9-38045BC0F95BQ36907849-1B5B0A9B-937C-46D2-B338-943F3800F645Q36988704-E4A68587-D89F-4849-9901-59440C75EF4AQ37084908-F226073F-1D83-4F75-A977-4B72D9FDED22Q37088471-D29EF9A8-3DC0-4A8C-A465-477259C5F070Q37215118-82985D2B-88C5-4B90-BA04-04AC0676995CQ37403682-0E5BE847-7F37-4554-ADAD-382D536FCC29Q37577405-B3C16A20-2569-42AE-9B4A-57E9A34093F0Q37640194-14E4881E-19E8-4C09-9779-1A3F22E4A723Q37655201-FA92A087-C00E-4A8C-9F12-28D9CECF5A52Q37826381-D68ADBD4-36AA-49CF-8B54-048E0A448734Q37831956-B1BA43DB-F5D3-443D-BCFA-BF9A3765BF91Q38095109-00FF672A-338E-4CEE-8698-948AC36AB51FQ38822438-45E6462C-AB10-44C6-8CD7-9DC73E95B681Q39020652-80637B95-D797-446E-8AA1-B36F9A2CB131
P2860
Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Expression of B-cell-attractin ...... ntral nervous system lymphoma.
@en
Expression of B-cell-attracting chemokine 1
@nl
type
label
Expression of B-cell-attractin ...... ntral nervous system lymphoma.
@en
Expression of B-cell-attracting chemokine 1
@nl
prefLabel
Expression of B-cell-attractin ...... ntral nervous system lymphoma.
@en
Expression of B-cell-attracting chemokine 1
@nl
P2093
P1433
P1476
Expression of B-cell-attractin ...... ntral nervous system lymphoma.
@en
P2093
James T Rosenbaum
Justine R Smith
Mariagrazia Uguccioni
Martin Lipp
Rita M Braziel
Samantha Paoletti
P304
P356
10.1182/BLOOD-2002-05-1576
P407
P577
2002-10-03T00:00:00Z